Class IIReported 2025-10-15

Thymosin Beta-4 (TB4) for Injection, 15mg, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

Recalled by GenoGenix LLC

Reason for Recall

Lack of Assurance of Sterility

Recall Number

D-0087-2026

Classification

Class II

Status

Ongoing

Category

drug

Initiated

2025-07-30

Reported

2025-10-15

Distribution

US Nationwide.

Code Info

Lot#: GG060525-001 within expiry.

Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.